TY  - GEN
AU  - Hamblin,Peter S
AU  - Wong,Rosemary
AU  - Ekinci,Elif I
AU  - Fourlanos,Spiros
AU  - Shah,Sonali
AU  - Jones,Alicia R
AU  - Hare,Matthew J L
AU  - Calder,Genevieve L
AU  - Epa,Dilan Seneviratne
AU  - George,Elizabeth M
AU  - Giri,Rinky
AU  - Kotowicz,Mark A
AU  - Kyi,Mervyn
AU  - Lafontaine,Nicole
AU  - MacIsaac,Richard J
AU  - Nolan,Brendan J
AU  - O'Neal,David N
AU  - Renouf,Debra
AU  - Varadarajan,Suresh
AU  - Wong,Jennifer
AU  - Xu,Sylvia
AU  - Bach,Leon A
TI  - SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission
SN  - 1945-7197
PY  - 2020///0520
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Blood Glucose
KW  - analysis
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Diabetic Ketoacidosis
KW  - chemically induced
KW  - Female
KW  - Hospitalization
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Sodium-Glucose Transporter 2 Inhibitors
KW  - adverse effects
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1210/jc.2019-00139
ER  -